Skip to main content
News & Events

Webinar – From scoping to systematic: Choosing the right literature review for your evidence needs

By September 25, 2026No Comments

Webinar advert

 

On Tuesday, 6 October 2026, Genesis Research Group’s evidence synthesis, HEOR, and evidence planning teams will be presenting a webinar in partnership with online real-world evidence and HEOR research hub The Evidence Base. The topic of the webinar is ‘From scoping to systematic: Choosing the right literature review for your evidence needs‘.

Overview

Navigate the literature review spectrum and gain practical insight into selecting the most appropriate review approach for your evidence needs.

Whether informing internal strategy discussions or supporting HTA submissions, literature reviews are used to answer a wide range of evidence needs across the pharmaceutical industry. From scoping and targeted to fully systematic literature reviews, understanding where different methodologies fit along the evidence synthesis spectrum is key to selecting the right approach.

This webinar will explore the spectrum of literature review methodologies, examine how different review types support varying evidence requirements and decision contexts, and discuss their role within integrated evidence generation planning (IEGP) to support more informed evidence decisions across the product lifecycle.

Designed for pharma and biotech professionals who plan, commission, or act on literature reviews, from HEOR and market access to medical affairs and evidence generation leads.

Register for the online event here

space

Learning Objectives

  • Become familiar with types of literature reviews and the terminology used to define them.
  • Understand how different literature review approaches vary in purpose, rigor, and resource requirements.
  • Recognize the trade-offs between breadth, speed, reproducibility, and methodological rigor.
  • Identify the strengths, limitations, and appropriate applications of different review types across common use cases.
  • Understand how different literature review methodologies fit within IEGP and support varying evidence requirements.

Speakers


Zarmina Khankhel
Senior Director, Evidence Synthesis, Genesis Research Group

Zarmina has 15+ years experience in HEOR and RWE consulting. She focuses on both qualitative (e.g., systematic and non-systematic literature reviews) and quantitative (e.g., feasibility assessment, meta-analysis, indirect treatment comparisons including network meta-analysis) evidence synthesis activities. In her role at Genesis, she leads the Evidence Synthesis team on global and region-specific projects across a wide range of disease areas and on projects supporting various needs including dossier development, data landscape assessment, evidence gap analysis, HTA, internal strategy support, modeling inputs, publication development and strategy, among others.

Samara Ferguson
Vice President, Head of HEOR, Genesis Research Group

Samara has 30+ years of experience in HEOR and market access across consulting and industry roles. Her expertise spans the full spectrum of market access and evidence strategy, including payer evidence generation, value proposition development, global value dossiers, economic modeling, and HTA submissions. In her role at Genesis, she leads the HEOR team, supporting pharmaceutical and biotech companies in communicating asset value across global and regional markets and helping clients navigate complex reimbursement and payer decision-making environments.

Priti Jhingran
Vice President, Head of HEOR Strategy & Partnerships, Genesis Research Group

Priti has 30+ years of experience in the pharmaceutical industry across consulting and industry roles. A recognized leader in market access, HTA, and evidence strategy, she has helped organizations understand evidence needs and develop approaches that inform access and reimbursement decisions across US and global markets. Priti has led enterprise-wide initiatives focused on value, evidence, and outcomes, supported the launch of more than 15 pharmaceutical products, and built high-performing Health Outcomes teams. She is a frequent speaker and author with more than 75 peer-reviewed publications in health economics, policy, and services research.

Register for the online event here

 

For further information, please contact Richard Chumbley at richard.chumbley@genesisrg.com.

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US